Jump to content

Main Page: Difference between revisions

No edit summary
today's topic update
Line 7: Line 7:
| style="width:50%; vertical-align:top; background-color:#F5FFFA;" | <div style="background-color:#CEF2E0; border:2px solid #A3BFB1; padding:8px; margin:2px 0px 3px 0px; text-align:left; width:auto; max-width:100%; display:block;">'''From Today's Controversial Topic'''</div>  
| style="width:50%; vertical-align:top; background-color:#F5FFFA;" | <div style="background-color:#CEF2E0; border:2px solid #A3BFB1; padding:8px; margin:2px 0px 3px 0px; text-align:left; width:auto; max-width:100%; display:block;">'''From Today's Controversial Topic'''</div>  


'''[[Topics:Human_Cloning/In_Utero_Gene_Editing|Human Cloning/In Utero Gene Editing]]''', The debate over in utero gene editing and human cloning combines aspects of biotechnology, ethics, and public policy, raising questions about the boundaries of scientific intervention in human life. Doctoral students were asked to take "Pro", "Con", and "In Between" positions regarding the usefulness and harm of Human Cloning/In Utero Gene Editing. ([[Topics:Human_Cloning/In_Utero_Gene_Editing|Full topic...]])
'''[[Topics:Pharmaceutical_Lobbying|Pharmaceutical_Lobbying]]''', Pharmaceutical industry lobbying comprises one of the most powerful and high spending corporate lobby groups in the United States, spearheaded by the PhRMA industry group. Doctoral students were asked to take "Pro", "Con", and "In Between" positions regarding the usefulness and harm of Pharmaceutical Lobbying. ([[Topics:Pharmaceutical_Lobbying|Full topic...]])


''Credit: Cavallaro, N; Simhadri, J''
''Credit: Morrisson, D.; Williamson, L.''
''(authors and sources listed alphabetically)''
''(authors and sources listed alphabetically)''
| style="width:50%; vertical-align:top; background-color:#F6FAFF;" |
| style="width:50%; vertical-align:top; background-color:#F6FAFF;" |
<div style="background-color:#CEDFF2; border:2px solid #A3B0BF; padding:8px; margin:2px 0px 3px 0px; text-align:left; width:auto; max-width:100%; display:block;">'''Today's Topic Discussion'''</div>
<div style="background-color:#CEDFF2; border:2px solid #A3B0BF; padding:8px; margin:2px 0px 3px 0px; text-align:left; width:auto; max-width:100%; display:block;">'''Today's Topic Discussion'''</div>
* '''Prevention of Genetic Diseases''': Gene editing technologies like CRISPR offer the ability to correct mutations that cause inherited diseases such as sickle cell anemia, Huntington’s disease, and cystic fibrosis.
* '''Expertise''': Congress has repeatedly passed bills that do substantial harm to the American pharmaceutical industry, with negative ramifications for pharmaceutical workers, consumers, and the country as a whole. Allowing PhRMA to lobby congress gives them a direct line to convince them to make better decisions for the country and for every stakeholder in the pharmaceutical industry. Ethical framing: Utilitarian
* '''Advancements in Regenerative Medicine''': Therapeutic cloning can produce genetically matched stem cells, which could be used to grow tissues or even organs for transplantation.
* '''Benefit to society''': While arguments about profiteering are valid, the pharma industry ultimately works to save lives and improve quality of life for tens of millions of Americans. The goals of the pharma industry are goals that all Americans should share, and allowing them to lobby congress helps them achieve an ethically sound goal as long as regulation exists to ensure that profiteering isn’t the primary goal of the lobbyists. Ethical framing: Deontological (rooted in social contract)
* '''Support for Infertile Couples and Reproductive Autonomy''': Reproductive cloning could offer a path to biological parenthood for individuals or couples who cannot conceive using traditional or assisted reproductive technologies.
* '''Systemic Fairness''': While there are issues with pharmaceutical lobbying that could be regulated better, it would be unfair to specifically target pharmaceutical industry, who’s goals and function contribute to improving the health and well-being of everybody who needs healthcare, while ignoring other corporate lobbying groups. Zooming out even further, specifically arguing against corporate lobby groups while ignoring other lobby groups like nonprofits, unions, policy thinktanks, and international groups unnecessarily targets companies. Ethical framing: Deontological (fairness based)
* '''Acceleration of Biomedical Research''': Both gene editing and therapeutic cloning provide powerful tools for studying human development and disease.
* '''Private-Public Cooperation''': Allowing pharmaceutical companies to lobby congress and federal agencies helps streamline the process of private-public collaboration in pharmaceutical and related healthcare applications. Private-public collaboration has produced societal projects with the greatest impact on improving qualify of life in America, and hindering corporate lobbying is a move in the wrong direction for creating more of these projects. Ethical framing: Both utilitarian and deontological (duty/social contract)
*'''Potential Cost Savings in Healthcare''': By preventing genetic diseases before birth or treating them at the molecular level, gene editing could reduce the need for long-term medical care, hospitalizations, and drug therapies.
* Lobbying practices have an inherent self-preserving interest given most groups have direct ties to the profit-driven industry. While they provide expertise for ongoing research, their profit-driven biases can result in presenting incomplete findings on treatments, promoting high drug prices, and relaxing drug testing &amp; distribution standards. This self-serving behavior can be demonstrated by the staggering amounts invested in campaign contributions and continually climbing U.S. drug prices.
|-
|-
| colspan="2" style="background-color:#FFF5FA;" |
| colspan="2" style="background-color:#FFF5FA;" |

Revision as of 12:32, 7 April 2025

Welcome to Unifiers' Movement

the Balanced Arguments to Global Issues.

From Today's Controversial Topic

Pharmaceutical_Lobbying, Pharmaceutical industry lobbying comprises one of the most powerful and high spending corporate lobby groups in the United States, spearheaded by the PhRMA industry group. Doctoral students were asked to take "Pro", "Con", and "In Between" positions regarding the usefulness and harm of Pharmaceutical Lobbying. (Full topic...)

Credit: Morrisson, D.; Williamson, L. (authors and sources listed alphabetically)

Today's Topic Discussion
  • Expertise: Congress has repeatedly passed bills that do substantial harm to the American pharmaceutical industry, with negative ramifications for pharmaceutical workers, consumers, and the country as a whole. Allowing PhRMA to lobby congress gives them a direct line to convince them to make better decisions for the country and for every stakeholder in the pharmaceutical industry. Ethical framing: Utilitarian
  • Benefit to society: While arguments about profiteering are valid, the pharma industry ultimately works to save lives and improve quality of life for tens of millions of Americans. The goals of the pharma industry are goals that all Americans should share, and allowing them to lobby congress helps them achieve an ethically sound goal as long as regulation exists to ensure that profiteering isn’t the primary goal of the lobbyists. Ethical framing: Deontological (rooted in social contract)
  • Systemic Fairness: While there are issues with pharmaceutical lobbying that could be regulated better, it would be unfair to specifically target pharmaceutical industry, who’s goals and function contribute to improving the health and well-being of everybody who needs healthcare, while ignoring other corporate lobbying groups. Zooming out even further, specifically arguing against corporate lobby groups while ignoring other lobby groups like nonprofits, unions, policy thinktanks, and international groups unnecessarily targets companies. Ethical framing: Deontological (fairness based)
  • Private-Public Cooperation: Allowing pharmaceutical companies to lobby congress and federal agencies helps streamline the process of private-public collaboration in pharmaceutical and related healthcare applications. Private-public collaboration has produced societal projects with the greatest impact on improving qualify of life in America, and hindering corporate lobbying is a move in the wrong direction for creating more of these projects. Ethical framing: Both utilitarian and deontological (duty/social contract)
  • Lobbying practices have an inherent self-preserving interest given most groups have direct ties to the profit-driven industry. While they provide expertise for ongoing research, their profit-driven biases can result in presenting incomplete findings on treatments, promoting high drug prices, and relaxing drug testing & distribution standards. This self-serving behavior can be demonstrated by the staggering amounts invested in campaign contributions and continually climbing U.S. drug prices.
About The Unifiers’ Movement (UM)

UM is a global non-profit organization which aims to engage interested scholars with differing views in examining important global societal issues and developing publishable respected arguments that can serve as trustworthy sources to individuals, families, organizations, governments, etc., to express their own informed positions on the issue. These positions will continue being re-examined as new evidence becomes available and being re-adjusted in addendum publications so that they can remain relevant and current. UM will know it is doing its job when it gets closest to achieving unification through a robust balance that becomes increasingly difficult to tip. (Read more...)

Unifiers' Movement Book
Unifiers' MovementBalanced arguments to global issues


Balanced arguments to Global IssuesDiomedes Logothetis

THE UNIFIERS’ MOVEMENT

Can the motivation for a unified problem-solving approach be to work together to leave the world a better place than we found it? A world contained by ethical boundaries, where we regain our trust and reject our fear of each other? A world unified and not divided?

This book proposes a path toward unifying solutions to problems!

Dedicated to: the next generation (to Adrian, Liam, co-authors: Adam, Dean, and all the children and grandchildren of the world)

Credit: John Basl (ch.1), David E. Clapham (ch.4), Miguel Fribourg-Casajuana (ch.6), Diomedes E. Logothetis (Prologue and ch.1-7), Frederick Sigworth (ch.3), Stelios M. Smirnakis (ch.2), Raimond Winslow (ch.6), Maurice Zaki, TBD (ch.5, ch.7) (authors listed alphabetically) 

Download / Buy Book